COBAS CRP TEST - COFEPRIS Registration 17R2022 SSA
Access comprehensive regulatory information for COBAS CRP TEST (COBAS CRP TEST) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 17R2022 SSA and manufactured by PRODUCTOSROCHE, S.A. DE C.V.. The device was registered on January 12, 2022.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.
PRUEBAINVITROPARALADETERMINACIÓNCUANTITATIVADELAPROTEÍNACREACTIVA(CRP),PORSUSSIGLASENINGLÉSPORMEDICIÓNFOTOMÉTRICAENSANGRETOTALCAPILARYSUEROHUMANO,ASÍCOMOENSANGRETOTALYPLASMAANTICOAGULADOSCONEDTADIYTRIPOTÁSICOYHEPARINA DE LITIO. LA DETERMINACIÓN DE CRP Y ELCONTROL ESTÁN DESTINADOS A LA EVALUACIÓN DEENFERMEDADES INFLAMATORIAS Y TRASTORNOSASOCIADOS, INFECCIONES Y DAÑO TISULAR. EL SISTEMAESTÁ DESTINADO AL USO EN PUNTOS DE ATENCIÓN ALPACIENTE (POINT OF C
AN IN-VITRO TEST FOR THE QUANTITATIVE DETERMINATION OF CREACTIVE PROTEIN (CRP), FOR PHOTOMETRIC MEASUREMENT IN TOTAL CAPILLARY BLOOD AND HUMAN SERUM, AS WELL AS IN TOTAL BLOOD AND PLASMA ANTICOAGULANTS WITH EDTADI, TRIPOTASSIC, AND LITHIUM HEPARIN. THE DETERMINATION OF CRP AND CONTROL ARE INTENDED FOR THE EVALUATION OF INFLAMMATORY DISEASES AND ASSOCIATED DISORDERS, INFECTIONS AND TISSUE DAMAGE. THE SYSTEM IS INTENDED FOR POINT-OF-CARE (POINT OF CARE) USE.